nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—Etoposide—uterine cancer	0.215	0.542	CbGbCtD
Ketorolac—PTGS1—Etoposide—uterine cancer	0.182	0.458	CbGbCtD
Ketorolac—PTGS1—oviduct—uterine cancer	0.00948	0.147	CbGeAlD
Ketorolac—PTGS1—artery—uterine cancer	0.00628	0.0972	CbGeAlD
Ketorolac—PTGS2—artery—uterine cancer	0.006	0.0929	CbGeAlD
Ketorolac—Tolmetin—CXCL8—uterine cancer	0.00467	0.672	CrCbGaD
Ketorolac—PTGS2—myometrium—uterine cancer	0.0029	0.0449	CbGeAlD
Ketorolac—PTGS1—epithelium—uterine cancer	0.00238	0.0369	CbGeAlD
Ketorolac—PTGS1—uterine cervix—uterine cancer	0.00236	0.0365	CbGeAlD
Ketorolac—PTGS1—smooth muscle tissue—uterine cancer	0.00229	0.0355	CbGeAlD
Ketorolac—Ketoprofen—CXCL8—uterine cancer	0.00228	0.328	CrCbGaD
Ketorolac—PTGS2—epithelium—uterine cancer	0.00227	0.0352	CbGeAlD
Ketorolac—PTGS2—uterine cervix—uterine cancer	0.00226	0.0349	CbGeAlD
Ketorolac—PTGS1—renal system—uterine cancer	0.00221	0.0342	CbGeAlD
Ketorolac—PTGS2—smooth muscle tissue—uterine cancer	0.00219	0.0339	CbGeAlD
Ketorolac—PTGS1—endometrium—uterine cancer	0.00213	0.0331	CbGeAlD
Ketorolac—PTGS2—renal system—uterine cancer	0.00211	0.0327	CbGeAlD
Ketorolac—PTGS1—mammalian vulva—uterine cancer	0.00206	0.032	CbGeAlD
Ketorolac—PTGS2—endometrium—uterine cancer	0.00204	0.0316	CbGeAlD
Ketorolac—PTGS1—uterus—uterine cancer	0.00197	0.0305	CbGeAlD
Ketorolac—PTGS2—uterus—uterine cancer	0.00188	0.0291	CbGeAlD
Ketorolac—PTGS1—female reproductive system—uterine cancer	0.00177	0.0274	CbGeAlD
Ketorolac—PTGS2—female reproductive system—uterine cancer	0.00169	0.0262	CbGeAlD
Ketorolac—PTGS1—female gonad—uterine cancer	0.00161	0.0249	CbGeAlD
Ketorolac—PTGS1—vagina—uterine cancer	0.0016	0.0248	CbGeAlD
Ketorolac—PTGS2—female gonad—uterine cancer	0.00154	0.0238	CbGeAlD
Ketorolac—PTGS2—vagina—uterine cancer	0.00153	0.0237	CbGeAlD
Ketorolac—PTGS1—lymph node—uterine cancer	0.00103	0.016	CbGeAlD
Ketorolac—PTGS2—lymph node—uterine cancer	0.000988	0.0153	CbGeAlD
Ketorolac—Hyperhidrosis—Etoposide—uterine cancer	0.000318	0.000599	CcSEcCtD
Ketorolac—Pancreatitis—Epirubicin—uterine cancer	0.000318	0.000599	CcSEcCtD
Ketorolac—Abdominal pain upper—Doxorubicin—uterine cancer	0.000317	0.000597	CcSEcCtD
Ketorolac—Hypokalaemia—Doxorubicin—uterine cancer	0.000316	0.000595	CcSEcCtD
Ketorolac—Breast disorder—Doxorubicin—uterine cancer	0.000314	0.000591	CcSEcCtD
Ketorolac—Anorexia—Etoposide—uterine cancer	0.000314	0.00059	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000313	0.000589	CcSEcCtD
Ketorolac—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000313	0.000589	CcSEcCtD
Ketorolac—Diarrhoea—Dactinomycin—uterine cancer	0.000311	0.000585	CcSEcCtD
Ketorolac—Nasopharyngitis—Doxorubicin—uterine cancer	0.000311	0.000584	CcSEcCtD
Ketorolac—Pancytopenia—Epirubicin—uterine cancer	0.000308	0.00058	CcSEcCtD
Ketorolac—Hypotension—Etoposide—uterine cancer	0.000308	0.000579	CcSEcCtD
Ketorolac—Gastritis—Doxorubicin—uterine cancer	0.000307	0.000578	CcSEcCtD
Ketorolac—Dysuria—Epirubicin—uterine cancer	0.000303	0.000571	CcSEcCtD
Ketorolac—Abdominal distension—Doxorubicin—uterine cancer	0.000302	0.000569	CcSEcCtD
Ketorolac—Asthma—Doxorubicin—uterine cancer	0.0003	0.000565	CcSEcCtD
Ketorolac—Pollakiuria—Epirubicin—uterine cancer	0.0003	0.000564	CcSEcCtD
Ketorolac—Eosinophilia—Doxorubicin—uterine cancer	0.000297	0.000559	CcSEcCtD
Ketorolac—Photosensitivity reaction—Epirubicin—uterine cancer	0.000296	0.000557	CcSEcCtD
Ketorolac—Paraesthesia—Etoposide—uterine cancer	0.000296	0.000556	CcSEcCtD
Ketorolac—Weight increased—Epirubicin—uterine cancer	0.000295	0.000556	CcSEcCtD
Ketorolac—Pancreatitis—Doxorubicin—uterine cancer	0.000294	0.000554	CcSEcCtD
Ketorolac—Dyspnoea—Etoposide—uterine cancer	0.000293	0.000552	CcSEcCtD
Ketorolac—Hyperglycaemia—Epirubicin—uterine cancer	0.000293	0.000551	CcSEcCtD
Ketorolac—Somnolence—Etoposide—uterine cancer	0.000293	0.000551	CcSEcCtD
Ketorolac—Pneumonia—Epirubicin—uterine cancer	0.000291	0.000547	CcSEcCtD
Ketorolac—Drowsiness—Epirubicin—uterine cancer	0.000289	0.000544	CcSEcCtD
Ketorolac—Vomiting—Dactinomycin—uterine cancer	0.000289	0.000544	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000287	0.00054	CcSEcCtD
Ketorolac—Rash—Dactinomycin—uterine cancer	0.000287	0.00054	CcSEcCtD
Ketorolac—Decreased appetite—Etoposide—uterine cancer	0.000286	0.000538	CcSEcCtD
Ketorolac—Pancytopenia—Doxorubicin—uterine cancer	0.000285	0.000536	CcSEcCtD
Ketorolac—Renal failure—Epirubicin—uterine cancer	0.000284	0.000535	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Etoposide—uterine cancer	0.000284	0.000535	CcSEcCtD
Ketorolac—Fatigue—Etoposide—uterine cancer	0.000284	0.000534	CcSEcCtD
Ketorolac—Stomatitis—Epirubicin—uterine cancer	0.000282	0.000531	CcSEcCtD
Ketorolac—Jaundice—Epirubicin—uterine cancer	0.000282	0.000531	CcSEcCtD
Ketorolac—Constipation—Etoposide—uterine cancer	0.000281	0.00053	CcSEcCtD
Ketorolac—Pain—Etoposide—uterine cancer	0.000281	0.00053	CcSEcCtD
Ketorolac—Conjunctivitis—Epirubicin—uterine cancer	0.000281	0.000529	CcSEcCtD
Ketorolac—Dysuria—Doxorubicin—uterine cancer	0.000281	0.000528	CcSEcCtD
Ketorolac—Sweating—Epirubicin—uterine cancer	0.000277	0.000522	CcSEcCtD
Ketorolac—Pollakiuria—Doxorubicin—uterine cancer	0.000277	0.000522	CcSEcCtD
Ketorolac—Haematuria—Epirubicin—uterine cancer	0.000276	0.000519	CcSEcCtD
Ketorolac—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000274	0.000516	CcSEcCtD
Ketorolac—Hepatobiliary disease—Epirubicin—uterine cancer	0.000274	0.000515	CcSEcCtD
Ketorolac—Weight increased—Doxorubicin—uterine cancer	0.000273	0.000514	CcSEcCtD
Ketorolac—Epistaxis—Epirubicin—uterine cancer	0.000273	0.000513	CcSEcCtD
Ketorolac—Feeling abnormal—Etoposide—uterine cancer	0.000271	0.00051	CcSEcCtD
Ketorolac—Hyperglycaemia—Doxorubicin—uterine cancer	0.000271	0.00051	CcSEcCtD
Ketorolac—Nausea—Dactinomycin—uterine cancer	0.00027	0.000508	CcSEcCtD
Ketorolac—Agranulocytosis—Epirubicin—uterine cancer	0.00027	0.000508	CcSEcCtD
Ketorolac—Pneumonia—Doxorubicin—uterine cancer	0.000269	0.000507	CcSEcCtD
Ketorolac—Gastrointestinal pain—Etoposide—uterine cancer	0.000269	0.000506	CcSEcCtD
Ketorolac—Drowsiness—Doxorubicin—uterine cancer	0.000268	0.000504	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000265	0.000499	CcSEcCtD
Ketorolac—Bradycardia—Epirubicin—uterine cancer	0.000264	0.000497	CcSEcCtD
Ketorolac—Renal failure—Doxorubicin—uterine cancer	0.000263	0.000495	CcSEcCtD
Ketorolac—Urticaria—Etoposide—uterine cancer	0.000261	0.000492	CcSEcCtD
Ketorolac—Haemoglobin—Epirubicin—uterine cancer	0.000261	0.000491	CcSEcCtD
Ketorolac—Stomatitis—Doxorubicin—uterine cancer	0.000261	0.000491	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—uterine cancer	0.000261	0.000491	CcSEcCtD
Ketorolac—Rhinitis—Epirubicin—uterine cancer	0.00026	0.00049	CcSEcCtD
Ketorolac—Abdominal pain—Etoposide—uterine cancer	0.00026	0.00049	CcSEcCtD
Ketorolac—Body temperature increased—Etoposide—uterine cancer	0.00026	0.00049	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—uterine cancer	0.00026	0.00049	CcSEcCtD
Ketorolac—Haemorrhage—Epirubicin—uterine cancer	0.00026	0.000489	CcSEcCtD
Ketorolac—Hepatitis—Epirubicin—uterine cancer	0.00026	0.000489	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—uterine cancer	0.000257	0.000483	CcSEcCtD
Ketorolac—Urinary tract disorder—Epirubicin—uterine cancer	0.000256	0.000483	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—uterine cancer	0.000255	0.00048	CcSEcCtD
Ketorolac—Connective tissue disorder—Epirubicin—uterine cancer	0.000255	0.00048	CcSEcCtD
Ketorolac—Urethral disorder—Epirubicin—uterine cancer	0.000255	0.000479	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000253	0.000476	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—uterine cancer	0.000252	0.000475	CcSEcCtD
Ketorolac—Visual impairment—Epirubicin—uterine cancer	0.00025	0.000471	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—uterine cancer	0.00025	0.00047	CcSEcCtD
Ketorolac—Erythema multiforme—Epirubicin—uterine cancer	0.000246	0.000462	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—uterine cancer	0.000245	0.00046	CcSEcCtD
Ketorolac—Eye disorder—Epirubicin—uterine cancer	0.000243	0.000457	CcSEcCtD
Ketorolac—Hypersensitivity—Etoposide—uterine cancer	0.000242	0.000456	CcSEcCtD
Ketorolac—Tinnitus—Epirubicin—uterine cancer	0.000242	0.000456	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—uterine cancer	0.000241	0.000454	CcSEcCtD
Ketorolac—Flushing—Epirubicin—uterine cancer	0.000241	0.000454	CcSEcCtD
Ketorolac—Cardiac disorder—Epirubicin—uterine cancer	0.000241	0.000454	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—uterine cancer	0.000241	0.000453	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—uterine cancer	0.00024	0.000452	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—uterine cancer	0.00024	0.000452	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—uterine cancer	0.000237	0.000447	CcSEcCtD
Ketorolac—Asthenia—Etoposide—uterine cancer	0.000236	0.000444	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—uterine cancer	0.000236	0.000444	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—uterine cancer	0.000236	0.000443	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—uterine cancer	0.000236	0.000443	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—uterine cancer	0.000235	0.000441	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—uterine cancer	0.000234	0.00044	CcSEcCtD
Ketorolac—Chills—Epirubicin—uterine cancer	0.000233	0.000438	CcSEcCtD
Ketorolac—Pruritus—Etoposide—uterine cancer	0.000233	0.000438	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—uterine cancer	0.000232	0.000437	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—uterine cancer	0.000232	0.000436	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—uterine cancer	0.000229	0.000432	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—uterine cancer	0.000227	0.000428	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—uterine cancer	0.000227	0.000427	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—uterine cancer	0.000226	0.000425	CcSEcCtD
Ketorolac—Erythema—Epirubicin—uterine cancer	0.000226	0.000425	CcSEcCtD
Ketorolac—Diarrhoea—Etoposide—uterine cancer	0.000225	0.000424	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—uterine cancer	0.000225	0.000423	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—uterine cancer	0.000224	0.000422	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—uterine cancer	0.000223	0.00042	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—uterine cancer	0.000223	0.00042	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—uterine cancer	0.000223	0.000419	CcSEcCtD
Ketorolac—Tension—Epirubicin—uterine cancer	0.000222	0.000417	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—uterine cancer	0.000221	0.000417	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—uterine cancer	0.00022	0.000413	CcSEcCtD
Ketorolac—Back pain—Epirubicin—uterine cancer	0.000219	0.000411	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—uterine cancer	0.000218	0.00041	CcSEcCtD
Ketorolac—Dizziness—Etoposide—uterine cancer	0.000218	0.00041	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—uterine cancer	0.000217	0.000408	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—uterine cancer	0.000217	0.000407	CcSEcCtD
Ketorolac—Chills—Doxorubicin—uterine cancer	0.000216	0.000406	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—uterine cancer	0.000215	0.000404	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—uterine cancer	0.000213	0.000401	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—uterine cancer	0.000212	0.0004	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—uterine cancer	0.00021	0.000396	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—uterine cancer	0.00021	0.000395	CcSEcCtD
Ketorolac—Vomiting—Etoposide—uterine cancer	0.000209	0.000394	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—uterine cancer	0.000209	0.000394	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—uterine cancer	0.000209	0.000394	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—uterine cancer	0.000209	0.000393	CcSEcCtD
Ketorolac—Agitation—Epirubicin—uterine cancer	0.000208	0.000391	CcSEcCtD
Ketorolac—Rash—Etoposide—uterine cancer	0.000208	0.00039	CcSEcCtD
Ketorolac—Dermatitis—Etoposide—uterine cancer	0.000207	0.00039	CcSEcCtD
Ketorolac—Headache—Etoposide—uterine cancer	0.000206	0.000388	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—uterine cancer	0.000206	0.000388	CcSEcCtD
Ketorolac—Tension—Doxorubicin—uterine cancer	0.000205	0.000386	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—uterine cancer	0.000205	0.000385	CcSEcCtD
Ketorolac—Malaise—Epirubicin—uterine cancer	0.000204	0.000384	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—uterine cancer	0.000203	0.000382	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—uterine cancer	0.000203	0.000382	CcSEcCtD
Ketorolac—Syncope—Epirubicin—uterine cancer	0.000203	0.000381	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—uterine cancer	0.000202	0.000381	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—uterine cancer	0.000202	0.000381	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—uterine cancer	0.0002	0.000376	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—uterine cancer	0.000199	0.000374	CcSEcCtD
Ketorolac—Cough—Epirubicin—uterine cancer	0.000197	0.000371	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—uterine cancer	0.000197	0.000371	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—uterine cancer	0.000196	0.000369	CcSEcCtD
Ketorolac—Nausea—Etoposide—uterine cancer	0.000195	0.000368	CcSEcCtD
Ketorolac—Hypertension—Epirubicin—uterine cancer	0.000195	0.000367	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—uterine cancer	0.000194	0.000365	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—uterine cancer	0.000193	0.000364	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—uterine cancer	0.000192	0.000362	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—uterine cancer	0.000192	0.000362	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—uterine cancer	0.000192	0.000362	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—uterine cancer	0.000192	0.000362	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—uterine cancer	0.000192	0.000361	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000191	0.00036	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—uterine cancer	0.00019	0.000358	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—uterine cancer	0.000189	0.000355	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—uterine cancer	0.000188	0.000354	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—uterine cancer	0.000188	0.000354	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—uterine cancer	0.000188	0.000353	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—uterine cancer	0.000187	0.000352	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—uterine cancer	0.000186	0.00035	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—uterine cancer	0.000185	0.000348	CcSEcCtD
Ketorolac—Oedema—Epirubicin—uterine cancer	0.000184	0.000347	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—uterine cancer	0.000184	0.000347	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—uterine cancer	0.000184	0.000346	CcSEcCtD
Ketorolac—Infection—Epirubicin—uterine cancer	0.000183	0.000345	CcSEcCtD
Ketorolac—Cough—Doxorubicin—uterine cancer	0.000183	0.000343	CcSEcCtD
Ketorolac—Shock—Epirubicin—uterine cancer	0.000182	0.000342	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—uterine cancer	0.000181	0.000341	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—uterine cancer	0.000181	0.00034	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—uterine cancer	0.000181	0.00034	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—uterine cancer	0.000181	0.00034	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—uterine cancer	0.00018	0.000339	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—uterine cancer	0.000179	0.000337	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—uterine cancer	0.000178	0.000336	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—uterine cancer	0.000178	0.000335	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—uterine cancer	0.000178	0.000335	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—uterine cancer	0.000178	0.000335	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—uterine cancer	0.000177	0.000334	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000177	0.000333	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—uterine cancer	0.000176	0.000331	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—uterine cancer	0.000176	0.000331	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—uterine cancer	0.000174	0.000328	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—uterine cancer	0.000172	0.000324	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—uterine cancer	0.000172	0.000324	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—uterine cancer	0.000171	0.000321	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—uterine cancer	0.000171	0.000321	CcSEcCtD
Ketorolac—Infection—Doxorubicin—uterine cancer	0.00017	0.000319	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000168	0.000316	CcSEcCtD
Ketorolac—Shock—Doxorubicin—uterine cancer	0.000168	0.000316	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—uterine cancer	0.000167	0.000315	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—uterine cancer	0.000167	0.000315	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—uterine cancer	0.000167	0.000314	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—uterine cancer	0.000167	0.000314	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—uterine cancer	0.000166	0.000312	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—uterine cancer	0.000166	0.000312	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—uterine cancer	0.000165	0.000311	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—uterine cancer	0.000164	0.00031	CcSEcCtD
Ketorolac—Somnolence—Epirubicin—uterine cancer	0.000164	0.000309	CcSEcCtD
Ketorolac—Anorexia—Doxorubicin—uterine cancer	0.000163	0.000306	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—uterine cancer	0.000162	0.000306	CcSEcCtD
Ketorolac—Decreased appetite—Epirubicin—uterine cancer	0.00016	0.000302	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—uterine cancer	0.00016	0.0003	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000159	0.0003	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—uterine cancer	0.000159	0.000299	CcSEcCtD
Ketorolac—Pain—Epirubicin—uterine cancer	0.000158	0.000297	CcSEcCtD
Ketorolac—Constipation—Epirubicin—uterine cancer	0.000158	0.000297	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000156	0.000293	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—uterine cancer	0.000154	0.000291	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—uterine cancer	0.000153	0.000288	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—uterine cancer	0.000152	0.000286	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—uterine cancer	0.000152	0.000286	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—uterine cancer	0.000152	0.000286	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—uterine cancer	0.000151	0.000284	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—uterine cancer	0.00015	0.000283	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—uterine cancer	0.000148	0.000279	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000147	0.000277	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—uterine cancer	0.000147	0.000277	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—uterine cancer	0.000147	0.000276	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—uterine cancer	0.000146	0.000275	CcSEcCtD
Ketorolac—Pain—Doxorubicin—uterine cancer	0.000146	0.000275	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—uterine cancer	0.000146	0.000274	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—uterine cancer	0.000146	0.000274	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—uterine cancer	0.000141	0.000265	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00014	0.000263	CcSEcCtD
Ketorolac—Hypersensitivity—Epirubicin—uterine cancer	0.000136	0.000256	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—uterine cancer	0.000136	0.000255	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—uterine cancer	0.000135	0.000254	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—uterine cancer	0.000135	0.000254	CcSEcCtD
Ketorolac—Asthenia—Epirubicin—uterine cancer	0.000132	0.000249	CcSEcCtD
Ketorolac—Pruritus—Epirubicin—uterine cancer	0.000131	0.000246	CcSEcCtD
Ketorolac—Diarrhoea—Epirubicin—uterine cancer	0.000126	0.000238	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—uterine cancer	0.000126	0.000237	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—uterine cancer	0.000122	0.00023	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—uterine cancer	0.000122	0.00023	CcSEcCtD
Ketorolac—Pruritus—Doxorubicin—uterine cancer	0.000121	0.000227	CcSEcCtD
Ketorolac—Vomiting—Epirubicin—uterine cancer	0.000117	0.000221	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—uterine cancer	0.000117	0.00022	CcSEcCtD
Ketorolac—Rash—Epirubicin—uterine cancer	0.000116	0.000219	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—uterine cancer	0.000116	0.000219	CcSEcCtD
Ketorolac—Headache—Epirubicin—uterine cancer	0.000116	0.000217	CcSEcCtD
Ketorolac—Dizziness—Doxorubicin—uterine cancer	0.000113	0.000212	CcSEcCtD
Ketorolac—Nausea—Epirubicin—uterine cancer	0.00011	0.000206	CcSEcCtD
Ketorolac—Vomiting—Doxorubicin—uterine cancer	0.000109	0.000204	CcSEcCtD
Ketorolac—Rash—Doxorubicin—uterine cancer	0.000108	0.000203	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—uterine cancer	0.000108	0.000202	CcSEcCtD
Ketorolac—Headache—Doxorubicin—uterine cancer	0.000107	0.000201	CcSEcCtD
Ketorolac—Nausea—Doxorubicin—uterine cancer	0.000101	0.000191	CcSEcCtD
